Safety of Intravenous Apramycin in Adults
Clinical trial NCT05590728 · COMPLETED
Trial details
- NCT number
- NCT05590728
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-16
- Primary completion
- 2023-10-22
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.